首页 > 最新文献

Regenerative Therapy最新文献

英文 中文
Printable biomaterials for 3D brain regenerative scaffolds: An in vivo biocompatibility assessment 3D脑再生支架的可打印生物材料:体内生物相容性评估
IF 3.5 3区 环境科学与生态学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-08-19 DOI: 10.1016/j.reth.2025.08.008
Maylis Combeau , Nina Colitti , Julien Clauzel , Franck Desmoulin , Adrien Brilhault , Juliette Fitremann , Mickaël Chabbert , Matthew L. Becker , Sébastien Blanquer , Lorenne Robert , Melissa Parny , Isabelle Raymond-Letron , Carla Cirillo , Isabelle Loubinoux

Background

Brain regeneration after injury is a challenge being tackled by numerous therapeutic strategies in pre-clinical development. There is growing interest in scaffolds implanted in brain lesions. Developments in 3D printing offer the possibility of designing complex structures of varying compositions adapted to tissue anatomy.

Methods

This feasibility study assessed the cerebral biocompatibility of four bioeliminable Digital Light Processing (DLP) printed materials in the rat model: gelatin methacrylate (GelMA), poly(ethylene glycol)diacrylate (PEGDA) mixed with GelMA (PEGDA-GelMA), poly(trimethylene carbonate) trimethacrylate (PTMC-tMA) and an ABA triblock copolymer of polypropylene fumarate-b-poly γ-methyl ε-caprolactone-b-polypropylene fumarate (P(PF-MCL-PF)). Their tolerance was compared to that of polydioxanone Ethicon (PDSII), a neurosurgery suture component commonly used in clinical practice. A one-month MRI and behavioral follow-up aided in safety assessment.

Results

High-resolution T2 MRI imaging effectively captured the scaffold structures and demonstrated its non-invasive utility in monitoring degradability. PDSII served as a control of the acceptable inflammatory response to implantable foreign bodies. GelMA, PEGDA-GelMA and PTMC-tMA did not affect the permissive glial barrier, promoted cell migration, and neovascularization without additional perilesional microglial inflammation (median mean of 6.5 %, compared to 8.2 % for the PDSII control). However, the GelMA scaffold core was not colonized and allowed a limited neuronal progenitors recruitment. The rigidity of PTMC-tMA facilitated insertion, but posed histological issues. The brain hardly reacted to the P(PF-MCL-PF).

Conclusion

All these materials can serve as a basis for brain regeneration. PEGDA-GelMA emerged as a promising candidate for intracerebral implantation, combining biophysical and bioprinting advantages while maintaining an acceptable level of inflammation compared with clinically used suture, paving the way for innovative therapies.
脑损伤后的再生是临床前开发中许多治疗策略所面临的挑战。人们对植入脑损伤部位的支架越来越感兴趣。3D打印的发展为设计适应组织解剖结构的不同组成的复杂结构提供了可能性。方法本可行性研究评估了四种生物可消除数字光处理(DLP)打印材料在大鼠模型中的脑生物相容性:甲基丙烯酸明胶(GelMA)、聚乙二醇二丙烯酸酯(PEGDA)与GelMA混合(PEGDA-GelMA)、聚碳酸三甲乙烯三甲丙烯酸酯(PTMC-tMA)和富马酸聚丙烯-b聚γ-甲基ε-己内酯-b-富马酸聚丙烯(P(PF-MCL-PF))的ABA三嵌段共聚物。将其耐受性与临床常用的神经外科缝合成分聚二氧环酮(PDSII)进行比较。一个月的核磁共振和行为随访有助于安全性评估。结果高分辨率T2 MRI成像可有效捕获支架结构,显示其在监测降解性方面的无创应用。PDSII作为可接受的炎症反应的控制植入式异物。GelMA, PEGDA-GelMA和PTMC-tMA不影响允许的胶质屏障,促进细胞迁移和新生血管,没有额外的病灶周围小胶质细胞炎症(中位平均值为6.5%,而PDSII对照组为8.2%)。然而,GelMA支架核心没有定植,并且允许有限的神经元祖细胞募集。PTMC-tMA的刚性促进了植入,但带来了组织学问题。大脑对P(PF-MCL-PF)几乎没有反应。结论这些材料可作为脑再生的基础材料。PEGDA-GelMA作为脑内植入的有希望的候选材料,结合了生物物理和生物打印的优势,同时与临床使用的缝合相比保持可接受的炎症水平,为创新疗法铺平了道路。
{"title":"Printable biomaterials for 3D brain regenerative scaffolds: An in vivo biocompatibility assessment","authors":"Maylis Combeau ,&nbsp;Nina Colitti ,&nbsp;Julien Clauzel ,&nbsp;Franck Desmoulin ,&nbsp;Adrien Brilhault ,&nbsp;Juliette Fitremann ,&nbsp;Mickaël Chabbert ,&nbsp;Matthew L. Becker ,&nbsp;Sébastien Blanquer ,&nbsp;Lorenne Robert ,&nbsp;Melissa Parny ,&nbsp;Isabelle Raymond-Letron ,&nbsp;Carla Cirillo ,&nbsp;Isabelle Loubinoux","doi":"10.1016/j.reth.2025.08.008","DOIUrl":"10.1016/j.reth.2025.08.008","url":null,"abstract":"<div><h3>Background</h3><div>Brain regeneration after injury is a challenge being tackled by numerous therapeutic strategies in pre-clinical development. There is growing interest in scaffolds implanted in brain lesions. Developments in 3D printing offer the possibility of designing complex structures of varying compositions adapted to tissue anatomy.</div></div><div><h3>Methods</h3><div>This feasibility study assessed the cerebral biocompatibility of four bioeliminable Digital Light Processing (DLP) printed materials in the rat model: gelatin methacrylate (GelMA), poly(ethylene glycol)diacrylate (PEGDA) mixed with GelMA (PEGDA-GelMA), poly(trimethylene carbonate) trimethacrylate (PTMC-tMA) and an ABA triblock copolymer of polypropylene fumarate-b-poly γ-methyl ε-caprolactone-b-polypropylene fumarate (P(PF-MCL-PF)). Their tolerance was compared to that of polydioxanone Ethicon (PDSII), a neurosurgery suture component commonly used in clinical practice. A one-month MRI and behavioral follow-up aided in safety assessment.</div></div><div><h3>Results</h3><div>High-resolution T2 MRI imaging effectively captured the scaffold structures and demonstrated its non-invasive utility in monitoring degradability. PDSII served as a control of the acceptable inflammatory response to implantable foreign bodies. GelMA, PEGDA-GelMA and PTMC-tMA did not affect the permissive glial barrier, promoted cell migration, and neovascularization without additional perilesional microglial inflammation (median mean of 6.5 %, compared to 8.2 % for the PDSII control). However, the GelMA scaffold core was not colonized and allowed a limited neuronal progenitors recruitment. The rigidity of PTMC-tMA facilitated insertion, but posed histological issues. The brain hardly reacted to the P(PF-MCL-PF).</div></div><div><h3>Conclusion</h3><div>All these materials can serve as a basis for brain regeneration. PEGDA-GelMA emerged as a promising candidate for intracerebral implantation, combining biophysical and bioprinting advantages while maintaining an acceptable level of inflammation compared with clinically used suture, paving the way for innovative therapies.</div></div>","PeriodicalId":20895,"journal":{"name":"Regenerative Therapy","volume":"30 ","pages":"Pages 641-655"},"PeriodicalIF":3.5,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144863985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conditioned plasma promotes full-thickness skin defect healing in a rat model 条件血浆促进大鼠模型全层皮肤缺损愈合
IF 3.5 3区 环境科学与生态学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-08-18 DOI: 10.1016/j.reth.2025.08.003
Majid Zamani , Saeid Kaviani , Mehdi Yousefi , Saeid Abroun , Mohammad Hojjat-Farsangi , Behzad Pourabbas

Introduction

Blood derivatives may enhance wound healing, but each possesses distinct characteristics and has yielded varying outcomes in patient treatment. This research seeks to examine the efficacy of conditioned plasma (CP) using polylactic acid (PLA) coated beads and to compare it with CP using bare beads and platelet-rich plasma (PRP) in the context of acute wound healing.

Methods

Blood was collected from 7 volunteer donors in three tubes containing ACD anticoagulant, PLA coated, or bare beads and incubated for 6 h at 37 °C. The concentration of VEGF, PDGF, TGF-β, IL-1β, IL-13, and IL-1Ra were measured by ELISA. Full-thickness wounds were made on the back of rats. PRP, CP with PLA-coated bead or bare beads, and phosphate buffer saline as control were administered to the wound area. Wound closure rate at days 3, 7, 10, and 14; epithelialization, fibroblast cells, inflammatory cells infiltration, new collagen formation, new vessel, and immunohistochemistry (CD31, α-SMA) were measured 14 days after the incision.

Results

The concentration of VEGF, PDGF, TGF-β, IL1-β, and IL-1Ra was significantly higher in CPs than in PRP (p < 0.05). CP with PLA-coated beads promoted wound closure and improved skin wound healing (p < 0.05), which was associated with enhanced epithelialization, fibroblast cell proliferation, new collagen formation, and reduced inflammatory cells infiltration. Immunohistochemistry showed an increase in CD31 and α-SMA levels in the treatment groups compared to the control group, but this increase was insignificant (p > 0.05).

Conclusion

CP promotes wound healing by increasing epithelialization, fibroblast proliferation, collagen synthesis and deposition, and reducing inflammatory cells infiltration.
血液衍生物可以促进伤口愈合,但每一种都具有不同的特性,在患者治疗中产生不同的结果。本研究旨在研究使用聚乳酸(PLA)包被微球的条件血浆(CP)在急性伤口愈合中的疗效,并将其与使用裸微球和富血小板血浆(PRP)的条件血浆(CP)进行比较。方法采集7名自愿献血者的血液,分别装在ACD抗凝剂、PLA包被或裸珠的3支试管中,37℃孵育6 h。采用ELISA法检测VEGF、PDGF、TGF-β、IL-1β、IL-13、IL-1Ra的浓度。在大鼠背部做全层创面。PRP, CP与pla包覆珠或裸珠,磷酸盐缓冲盐水作为对照施用于创面。第3、7、10、14天伤口愈合率;术后14 d,观察大鼠上皮化、成纤维细胞、炎性细胞浸润、新胶原形成、新血管及免疫组化(CD31、α-SMA)的变化。结果CPs中VEGF、PDGF、TGF-β、il -1 -β、IL-1Ra浓度显著高于PRP (p < 0.05)。CP与pla包被珠促进伤口闭合,改善皮肤伤口愈合(p < 0.05),这与增强上皮化、成纤维细胞增殖、新胶原形成和减少炎症细胞浸润有关。免疫组化结果显示,各治疗组CD31和α-SMA水平较对照组升高,但差异无统计学意义(p > 0.05)。结论cp可促进创面上皮化、成纤维细胞增殖、胶原合成和沉积,减少炎症细胞浸润,促进创面愈合。
{"title":"Conditioned plasma promotes full-thickness skin defect healing in a rat model","authors":"Majid Zamani ,&nbsp;Saeid Kaviani ,&nbsp;Mehdi Yousefi ,&nbsp;Saeid Abroun ,&nbsp;Mohammad Hojjat-Farsangi ,&nbsp;Behzad Pourabbas","doi":"10.1016/j.reth.2025.08.003","DOIUrl":"10.1016/j.reth.2025.08.003","url":null,"abstract":"<div><h3>Introduction</h3><div>Blood derivatives may enhance wound healing, but each possesses distinct characteristics and has yielded varying outcomes in patient treatment. This research seeks to examine the efficacy of conditioned plasma (CP) using polylactic acid (PLA) coated beads and to compare it with CP using bare beads and platelet-rich plasma (PRP) in the context of acute wound healing.</div></div><div><h3>Methods</h3><div>Blood was collected from 7 volunteer donors in three tubes containing ACD anticoagulant, PLA coated, or bare beads and incubated for 6 h at 37 °C. The concentration of VEGF, PDGF, TGF-β, IL-1β, IL-13, and IL-1Ra were measured by ELISA. Full-thickness wounds were made on the back of rats. PRP, CP with PLA-coated bead or bare beads, and phosphate buffer saline as control were administered to the wound area. Wound closure rate at days 3, 7, 10, and 14; epithelialization, fibroblast cells, inflammatory cells infiltration, new collagen formation, new vessel, and immunohistochemistry (CD31, α-SMA) were measured 14 days after the incision.</div></div><div><h3>Results</h3><div>The concentration of VEGF, PDGF, TGF-β, IL1-β, and IL-1Ra was significantly higher in CPs than in PRP (<em>p</em> &lt; 0.05). CP with PLA-coated beads promoted wound closure and improved skin wound healing (<em>p</em> &lt; 0.05), which was associated with enhanced epithelialization, fibroblast cell proliferation, new collagen formation, and reduced inflammatory cells infiltration. Immunohistochemistry showed an increase in CD31 and α-SMA levels in the treatment groups compared to the control group, but this increase was insignificant (<em>p</em> &gt; 0.05).</div></div><div><h3>Conclusion</h3><div>CP promotes wound healing by increasing epithelialization, fibroblast proliferation, collagen synthesis and deposition, and reducing inflammatory cells infiltration.</div></div>","PeriodicalId":20895,"journal":{"name":"Regenerative Therapy","volume":"30 ","pages":"Pages 629-640"},"PeriodicalIF":3.5,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144863984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracellular vesicles-delivered circDB promotes ischemic muscle repair through the miR-34a/USP7/Notch1 signaling pathway 细胞外小泡递送的circDB通过miR-34a/USP7/Notch1信号通路促进缺血肌肉修复
IF 3.5 3区 环境科学与生态学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-08-16 DOI: 10.1016/j.reth.2025.08.009
Lijuan Jiao , Qingfang Han , Yan Xu , Wenjie Chen , Tonggan Lu , Huiling Zhang , Anqi Zhou , Weiliang Wu , Yu Zhang , Ao Li , Yangxin Li

Introduction

The incidence of lower limb ischemic diseases has been rising steadily in recent years, often leading to severe outcomes such as limb amputation. Given the limited availability of effective treatments, there is a critical need for novel therapeutic strategies. This study explores the reparative role and underlying mechanisms of extracellular vesicles derived from human umbilical cord mesenchymal stem cells (UMSC-EVs) in promoting ischemic hindlimb recovery through the delivery of circular RNA circDB.

Methods

A hindlimb ischemia model was established in C57BL/6 mice via femoral artery ligation, followed by intramuscular injections of extracellular vesicles derived from either untreated UMSCs (NC-EVs) or UMSCs transfected with si-circDB (si-EVs). Functional recovery was assessed using Laser Doppler imaging for blood flow, grip strength tests, and treadmill endurance evaluations. Molecular analyses included Western blot and qRT-PCR for USP7 and Notch1 expression, EdU assays for myoblast proliferation, and co-immunoprecipitation to confirm USP7-Notch1 interactions. In vitro, C2C12 myoblasts were cultured under hypoxic conditions for 48 h to mimic ischemia, and their proliferation and signaling were studied using similar techniques. Bioinformatics tools (CircBank, TargetScan) were used to analyze circDB-miR-34a interactions.

Results

We found that circDB expression is markedly reduced in ischemic hindlimb tissues and is closely associated with tissue repair. In a murine hindlimb ischemia model, localized injection of UMSC-EVs into ischemic muscle significantly enhanced blood flow recovery, improved muscle function, and increased expression of USP7 and Notch1. Additionally, a hypoxia-induced myoblast injury model in vitro revealed that UMSC-EVs delivering circDB promoted myoblast proliferation via the miR-34a/USP7/Notch1 signaling axis.

Conclusion

Extracellular vesicles circDB enhances ischemic muscle repair by modulating the miR-34a/USP7/Notch1 pathway. These findings highlight a novel mechanism by which UMSC-derived extracellular vesicles facilitate muscle regeneration and suggest a promising therapeutic approach for lower limb ischemic diseases.
近年来,下肢缺血性疾病的发病率稳步上升,往往导致截肢等严重后果。鉴于有效治疗的可用性有限,迫切需要新的治疗策略。本研究探讨了来自人脐带间充质干细胞(umsc - ev)的细胞外囊泡通过递送环状RNA circDB促进缺血性后肢恢复的修复作用和潜在机制。方法通过股动脉结扎建立C57BL/6小鼠后肢缺血模型,然后肌内注射未经处理的UMSCs (nc - ev)或转染si-circDB的UMSCs (si- ev)的细胞外囊泡。使用激光多普勒成像血流、握力测试和跑步机耐力评估来评估功能恢复。分子分析包括Western blot和qRT-PCR检测USP7和Notch1的表达,EdU检测成肌细胞增殖,以及共免疫沉淀来确认USP7-Notch1的相互作用。体外模拟缺血,在缺氧条件下培养C2C12成肌细胞48 h,采用类似技术研究C2C12成肌细胞的增殖和信号传导。使用生物信息学工具(CircBank, TargetScan)分析circDB-miR-34a的相互作用。结果我们发现circDB在缺血后肢组织中表达明显降低,与组织修复密切相关。在小鼠后肢缺血模型中,局部向缺血肌肉注射umsc - ev可显著促进血流恢复,改善肌肉功能,并增加USP7和Notch1的表达。此外,体外缺氧诱导的成肌细胞损伤模型显示,传递circDB的umsc - ev通过miR-34a/USP7/Notch1信号轴促进成肌细胞增殖。结论细胞外囊泡circDB通过调控miR-34a/USP7/Notch1通路增强缺血肌肉修复。这些发现强调了umsc来源的细胞外囊泡促进肌肉再生的新机制,并为下肢缺血性疾病的治疗提供了一个有希望的方法。
{"title":"Extracellular vesicles-delivered circDB promotes ischemic muscle repair through the miR-34a/USP7/Notch1 signaling pathway","authors":"Lijuan Jiao ,&nbsp;Qingfang Han ,&nbsp;Yan Xu ,&nbsp;Wenjie Chen ,&nbsp;Tonggan Lu ,&nbsp;Huiling Zhang ,&nbsp;Anqi Zhou ,&nbsp;Weiliang Wu ,&nbsp;Yu Zhang ,&nbsp;Ao Li ,&nbsp;Yangxin Li","doi":"10.1016/j.reth.2025.08.009","DOIUrl":"10.1016/j.reth.2025.08.009","url":null,"abstract":"<div><h3>Introduction</h3><div>The incidence of lower limb ischemic diseases has been rising steadily in recent years, often leading to severe outcomes such as limb amputation. Given the limited availability of effective treatments, there is a critical need for novel therapeutic strategies. This study explores the reparative role and underlying mechanisms of extracellular vesicles derived from human umbilical cord mesenchymal stem cells (UMSC-EVs) in promoting ischemic hindlimb recovery through the delivery of circular RNA circDB.</div></div><div><h3>Methods</h3><div>A hindlimb ischemia model was established in C57BL/6 mice <em>via</em> femoral artery ligation, followed by intramuscular injections of extracellular vesicles derived from either untreated UMSCs (NC-EVs) or UMSCs transfected with si-circDB (si-EVs). Functional recovery was assessed using Laser Doppler imaging for blood flow, grip strength tests, and treadmill endurance evaluations. Molecular analyses included Western blot and qRT-PCR for USP7 and Notch1 expression, EdU assays for myoblast proliferation, and co-immunoprecipitation to confirm USP7-Notch1 interactions. <em>In vitro</em>, C2C12 myoblasts were cultured under hypoxic conditions for 48 h to mimic ischemia, and their proliferation and signaling were studied using similar techniques. Bioinformatics tools (CircBank, TargetScan) were used to analyze circDB-miR-34a interactions.</div></div><div><h3>Results</h3><div>We found that circDB expression is markedly reduced in ischemic hindlimb tissues and is closely associated with tissue repair. In a murine hindlimb ischemia model, localized injection of UMSC-EVs into ischemic muscle significantly enhanced blood flow recovery, improved muscle function, and increased expression of USP7 and Notch1. Additionally, a hypoxia-induced myoblast injury model <em>in vitro</em> revealed that UMSC-EVs delivering circDB promoted myoblast proliferation <em>via</em> the miR-34a/USP7/Notch1 signaling axis.</div></div><div><h3>Conclusion</h3><div>Extracellular vesicles circDB enhances ischemic muscle repair by modulating the miR-34a/USP7/Notch1 pathway. These findings highlight a novel mechanism by which UMSC-derived extracellular vesicles facilitate muscle regeneration and suggest a promising therapeutic approach for lower limb ischemic diseases.</div></div>","PeriodicalId":20895,"journal":{"name":"Regenerative Therapy","volume":"30 ","pages":"Pages 616-628"},"PeriodicalIF":3.5,"publicationDate":"2025-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144852227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of long-shelf-life allogeneic adipose-derived mesenchymal stem cell line-derived platelet-like cells for refractory foot ulcers: A translational preclinical and phase 1/2a study 长保质期异体脂肪来源的间充质干细胞系来源的血小板样细胞治疗难治性足溃疡的安全性和有效性:一项转化性临床前和1/2a期研究
IF 3.5 3区 环境科学与生态学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-08-14 DOI: 10.1016/j.reth.2025.08.006
Hideaki Obara , Kentaro Matsubara , Naoki Fujimura , Yumiko Matsubara , Yukako Ono-Uruga , Masaki Yazawa , Jun Okui , Yasunori Sato , Yuko Kitagawa

Introduction

Refractory foot ulcers, characterized by prolonged healing and frequent recurrences, challenge existing therapies such as revascularization and compression, which typically fail to prevent amputation. We developed adipose-derived mesenchymal stem cell line-derived platelet-like cells (ASCL-PLCs) for refractory ulcers that are long-lasting and readily available.

Methods

A translational preclinical investigation and phase 1/2a first-in-human clinical study assessed the safety and efficacy of a novel allogeneic ASCL-PLC treatment for refractory foot ulcers. In the pre-clinical phase, ASCL-PLCs were cryopreserved for 9 months and then thawed to measure cytokine release after calcium chloride stimulation. The therapeutic efficacy was evaluated in a diabetic mouse wound model, comparing ASCL-PLC treatment with vehicle control. The clinical trial involved topically applying ASCL-PLCs (1.5 × 108 cells/cm2) to the ulcers of four patients (two ischemic, two venous) on days 0, 14, and 28, with safety and efficacy monitored based on adverse events, ulcer size reduction, epithelialization time, and pain score changes.

Results

ASCL-PLCs maintained considerable cytokine-releasing activity even after long-term cryopreservation. In the diabetic mouse skin defect model, treatment with ASCL-PLCs substantially enhanced wound closure compared with the controls, demonstrating potent wound-healing capabilities. In the clinical trial, all patients exhibited notable ulcer size reduction without serious adverse events; three achieved epithelialization within 6 months, along with improvements in pain and quality of life without a negative impact on local blood flow.

Conclusions

ASCL-PLCs are safe and a promising therapeutic option for refractory ulcers and can potentially reduce amputation rates, improve patient outcomes, and minimize the socioeconomic impact due to chronic wounds. Their long shelf life and cryopreservation stability make wound management practical and accessible. Moreover, their efficacy with simple topical application suggests a minimally invasive strategy suitable for outpatient care. Further large-scale trials are recommended.
This study was registered with the Japan Registry of Clinical Trials (jRCT ID: jRCTa030200053; on June 18, 2020, https://jrct.mhlw.go.jp/en-latest-detail/jRCTa030200053).
难治性足部溃疡的特点是愈合时间长,复发频繁,对现有的治疗方法(如血运重建术和压迫术)提出了挑战,这些治疗方法通常不能防止截肢。我们开发了脂肪来源的间充质干细胞系衍生的血小板样细胞(ascl - plc),用于治疗难治性溃疡,这种细胞持久且容易获得。方法一项临床前研究和1/2a期首次人体临床研究评估了一种新型异体ASCL-PLC治疗难治性足部溃疡的安全性和有效性。在临床前阶段,ascl - plc冷冻保存9个月,然后解冻,以测量氯化钙刺激后细胞因子的释放。采用糖尿病小鼠创面模型,比较ASCL-PLC治疗与对照治疗的疗效。临床试验包括在第0、14和28天将ascl - plc (1.5 × 108细胞/cm2)局部应用于4例患者(2例缺血性,2例静脉)的溃疡,并根据不良事件、溃疡大小缩小、上皮化时间和疼痛评分变化监测安全性和有效性。结果ascl - plc在长期冷冻保存后仍保持相当高的细胞因子释放活性。在糖尿病小鼠皮肤缺损模型中,与对照组相比,ascl - plc治疗显著增强了伤口愈合,显示出强大的伤口愈合能力。在临床试验中,所有患者均表现出明显的溃疡缩小,无严重不良事件;3例患者在6个月内实现了上皮化,疼痛和生活质量得到改善,且对局部血流没有负面影响。结论sascl - plc是一种安全且有前景的治疗顽固性溃疡的选择,可以潜在地降低截肢率,改善患者预后,并最大限度地减少慢性伤口造成的社会经济影响。它们的长保质期和低温保存稳定性使伤口管理实用和方便。此外,他们的疗效与简单的局部应用建议微创策略适合门诊护理。建议进一步进行大规模试验。本研究已在日本临床试验注册中心注册(jRCT ID: jRCTa030200053;2020年6月18日,https://jrct.mhlw.go.jp/en-latest-detail/jRCTa030200053)。
{"title":"Safety and efficacy of long-shelf-life allogeneic adipose-derived mesenchymal stem cell line-derived platelet-like cells for refractory foot ulcers: A translational preclinical and phase 1/2a study","authors":"Hideaki Obara ,&nbsp;Kentaro Matsubara ,&nbsp;Naoki Fujimura ,&nbsp;Yumiko Matsubara ,&nbsp;Yukako Ono-Uruga ,&nbsp;Masaki Yazawa ,&nbsp;Jun Okui ,&nbsp;Yasunori Sato ,&nbsp;Yuko Kitagawa","doi":"10.1016/j.reth.2025.08.006","DOIUrl":"10.1016/j.reth.2025.08.006","url":null,"abstract":"<div><h3>Introduction</h3><div>Refractory foot ulcers, characterized by prolonged healing and frequent recurrences, challenge existing therapies such as revascularization and compression, which typically fail to prevent amputation. We developed adipose-derived mesenchymal stem cell line-derived platelet-like cells (ASCL-PLCs) for refractory ulcers that are long-lasting and readily available.</div></div><div><h3>Methods</h3><div>A translational preclinical investigation and phase 1/2a first-in-human clinical study assessed the safety and efficacy of a novel allogeneic ASCL-PLC treatment for refractory foot ulcers. In the pre-clinical phase, ASCL-PLCs were cryopreserved for 9 months and then thawed to measure cytokine release after calcium chloride stimulation. The therapeutic efficacy was evaluated in a diabetic mouse wound model, comparing ASCL-PLC treatment with vehicle control. The clinical trial involved topically applying ASCL-PLCs (1.5 × 10<sup>8</sup> cells/cm<sup>2</sup>) to the ulcers of four patients (two ischemic, two venous) on days 0, 14, and 28, with safety and efficacy monitored based on adverse events, ulcer size reduction, epithelialization time, and pain score changes.</div></div><div><h3>Results</h3><div>ASCL-PLCs maintained considerable cytokine-releasing activity even after long-term cryopreservation. In the diabetic mouse skin defect model, treatment with ASCL-PLCs substantially enhanced wound closure compared with the controls, demonstrating potent wound-healing capabilities. In the clinical trial, all patients exhibited notable ulcer size reduction without serious adverse events; three achieved epithelialization within 6 months, along with improvements in pain and quality of life without a negative impact on local blood flow.</div></div><div><h3>Conclusions</h3><div>ASCL-PLCs are safe and a promising therapeutic option for refractory ulcers and can potentially reduce amputation rates, improve patient outcomes, and minimize the socioeconomic impact due to chronic wounds. Their long shelf life and cryopreservation stability make wound management practical and accessible. Moreover, their efficacy with simple topical application suggests a minimally invasive strategy suitable for outpatient care. Further large-scale trials are recommended.</div><div>This study was registered with the Japan Registry of Clinical Trials (jRCT ID: jRCTa030200053; on June 18, 2020, <span><span>https://jrct.mhlw.go.jp/en-latest-detail/jRCTa030200053</span><svg><path></path></svg></span>).</div></div>","PeriodicalId":20895,"journal":{"name":"Regenerative Therapy","volume":"30 ","pages":"Pages 606-615"},"PeriodicalIF":3.5,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144828644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stem/progenitor cell dynamics during salivary gland development and regeneration demonstrated by the double pulse-chase paradigm 在唾液腺发育和再生过程中,干细胞/祖细胞动力学被双脉冲追逐范式证明
IF 3.5 3区 环境科学与生态学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-08-13 DOI: 10.1016/j.reth.2025.08.007
Shusuke Ohshima , Angela Quispe-Salcedo , Hiroko Ida-Yonemochi , Yushi Ueki , Arata Horii , Hayato Ohshima

Introduction

Active and quiescent stem cells coexist in hair follicles and intestinal crypts; however, their localization and differentiation potential in the salivary dynamics are unknown. This study aimed to clarify the cellular dynamics that occur during salivary gland development and regeneration in the duct ligation model with a focus on the role of label retaining cells (LRCs), presumably quiescent stem cells, in these processes.

Methods

Doxycycline-inducible TetOP-histone 2B (H2B)-green fluorescent protein (GFP) transgenic mice [GFP expression was induced during embryonic day 15 (E15)–postnatal day 7 (P7)] followed by EdU (5-ethynyl-2′-deoxyuridine) administration at P10–14 to chase the LRCs during development. In addition, LRCs were labeled with GFP immediately before salivary gland duct ligation and EdU was administered after the ligation was released to chase the LRCs with GFP and EdU during tissue repair.

Results and conclusions

During development, GFP (+) EdU (−) LRCs were abundant in striated duct cells (SDCs) and GFP (+) EdU (+) LRCs were primarily localized to the intercalated duct cells (IDCs) at P21. Labeling of the GFP (+) LRCs faded as well as the EdU (+) LRCs at P70. During tissue repair, GFP (+) EdU (+) LRCs were colocalized in the IDCs and myoepithelium cells (MECs), whereas the GFP (+) EdU (+) acinar cells (ACs) appeared over time. These results suggest that salivary gland quiescent stem/progenitor cells are present in the IDCs during development and that quiescent stem/progenitor cells in the IDCs and MECs differentiate into ACs during tissue repair.
活性干细胞和静止干细胞在毛囊和肠隐窝中共存;然而,它们在唾液动力学中的定位和分化潜力尚不清楚。本研究旨在阐明在导管结扎模型中唾液腺发育和再生过程中发生的细胞动力学,重点关注标签保留细胞(lrc),可能是静止干细胞在这些过程中的作用。方法多西环素诱导的tetop -组蛋白2B (H2B)-绿色荧光蛋白(GFP)转基因小鼠[在胚胎第15天(E15) -出生后第7天(P7)诱导GFP表达],然后在P10-14天给药EdU(5-乙基-2′-脱氧尿苷)追踪发育过程中的LRCs。此外,在结扎唾液腺导管前立即用GFP标记lrc,在结扎解除后给予EdU,在组织修复过程中用GFP和EdU追赶lrc。结果和结论在发育过程中,GFP (+) EdU(−)LRCs大量存在于纹状管细胞(SDCs)中,GFP (+) EdU (+) LRCs主要分布于P21的插层管细胞(IDCs)中。标记GFP (+) LRCs和EdU (+) LRCs在P70时褪色。在组织修复过程中,GFP (+) EdU (+) lrc共定位于IDCs和肌上皮细胞(MECs),而随着时间的推移,GFP (+) EdU(+)腺泡细胞(ACs)出现。这些结果表明,唾液腺静止干细胞/祖细胞在发育过程中存在于IDCs中,并且在组织修复过程中,IDCs和MECs中的静止干细胞/祖细胞分化为ACs。
{"title":"Stem/progenitor cell dynamics during salivary gland development and regeneration demonstrated by the double pulse-chase paradigm","authors":"Shusuke Ohshima ,&nbsp;Angela Quispe-Salcedo ,&nbsp;Hiroko Ida-Yonemochi ,&nbsp;Yushi Ueki ,&nbsp;Arata Horii ,&nbsp;Hayato Ohshima","doi":"10.1016/j.reth.2025.08.007","DOIUrl":"10.1016/j.reth.2025.08.007","url":null,"abstract":"<div><h3>Introduction</h3><div>Active and quiescent stem cells coexist in hair follicles and intestinal crypts; however, their localization and differentiation potential in the salivary dynamics are unknown. This study aimed to clarify the cellular dynamics that occur during salivary gland development and regeneration in the duct ligation model with a focus on the role of label retaining cells (LRCs), presumably quiescent stem cells, in these processes.</div></div><div><h3>Methods</h3><div>Doxycycline-inducible TetOP-histone 2B (H2B)-green fluorescent protein (GFP) transgenic mice [GFP expression was induced during embryonic day 15 (E15)–postnatal day 7 (P7)] followed by EdU (5-ethynyl-2′-deoxyuridine) administration at P10–14 to chase the LRCs during development. In addition, LRCs were labeled with GFP immediately before salivary gland duct ligation and EdU was administered after the ligation was released to chase the LRCs with GFP and EdU during tissue repair.</div></div><div><h3>Results and conclusions</h3><div>During development, GFP (+) EdU (−) LRCs were abundant in striated duct cells (SDCs) and GFP (+) EdU (+) LRCs were primarily localized to the intercalated duct cells (IDCs) at P21. Labeling of the GFP (+) LRCs faded as well as the EdU (+) LRCs at P70. During tissue repair, GFP (+) EdU (+) LRCs were colocalized in the IDCs and myoepithelium cells (MECs), whereas the GFP (+) EdU (+) acinar cells (ACs) appeared over time. These results suggest that salivary gland quiescent stem/progenitor cells are present in the IDCs during development and that quiescent stem/progenitor cells in the IDCs and MECs differentiate into ACs during tissue repair.</div></div>","PeriodicalId":20895,"journal":{"name":"Regenerative Therapy","volume":"30 ","pages":"Pages 595-605"},"PeriodicalIF":3.5,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144828643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CRISPR/Cas9 a genomic engineering technology for treatment in ALS mouse models CRISPR/Cas9基因工程技术用于治疗ALS小鼠模型
IF 3.5 3区 环境科学与生态学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-08-13 DOI: 10.1016/j.reth.2025.07.009
Hamid Khan , Hammad Riaz , Adeel Ahmed , Mubin Mustafa Kiyani , Sahibzada Muhammad Jawad , Syed Shahab Ud Din Shah , Turki Abualait , Fawaz Al-hussain , Hong-Tao Li , Shahid Bashir
Amyotrophic Lateral Sclerosis (ALS) is a complex neurodegenerative disorder characterized by the death of motor neurons in the spinal cord and brain regions, leading to a reduced survival rate in patients. Nearly 20 gene mutations are associated with ALS, with SOD1, FUS, TARDBP, and C9orf72 mutations being more common. Ninety percent of ALS cases are related to sporadic ALS, while the remaining 10 % are associated with familial ALS. CRISPR/Cas9, a genome engineering technology known as clustered regularly interspaced short palindromic repeats/CRISPR-associated system 9, has the potential for gene editing and for studying the underlying mechanisms of ALS in mouse models. This technique enables neuroscientists to reverse mutations found in ALS mouse models, providing new hope for understanding the complexities of ALS. Additionally, this tool can create mutations to probe the functional changes of genetic diseases. Using CRISPR/Cas9 with an in vivo delivery method involving adeno-associated vectors, it is possible to silence mutations in the SOD1-linked ALS mouse model. Some limitations related to CRISPR/Cas9 have been discussed in previous studies and need to be addressed before clinical trials can proceed. In this review-based study, we summarise the latest research on CRISPR/Cas9 genome editing for ALS in mouse models and discuss its limitations and future prospects as well.
肌萎缩性侧索硬化症(ALS)是一种复杂的神经退行性疾病,其特征是脊髓和大脑区域的运动神经元死亡,导致患者存活率降低。近20个基因突变与ALS相关,其中SOD1、FUS、TARDBP和C9orf72突变更为常见。90%的ALS病例与散发性ALS有关,而剩下的10%与家族性ALS有关。CRISPR/Cas9是一种被称为集群规则间隔短回文重复序列/CRISPR相关系统9的基因组工程技术,具有基因编辑和研究小鼠模型中ALS潜在机制的潜力。这项技术使神经科学家能够逆转在ALS小鼠模型中发现的突变,为理解ALS的复杂性提供了新的希望。此外,该工具可以创建突变来探测遗传疾病的功能变化。使用CRISPR/Cas9和涉及腺相关载体的体内递送方法,可以沉默sod1相关ALS小鼠模型中的突变。在之前的研究中已经讨论过与CRISPR/Cas9相关的一些限制,需要在进行临床试验之前加以解决。在这项基于综述的研究中,我们总结了CRISPR/Cas9基因组编辑用于ALS小鼠模型的最新研究,并讨论了其局限性和未来前景。
{"title":"CRISPR/Cas9 a genomic engineering technology for treatment in ALS mouse models","authors":"Hamid Khan ,&nbsp;Hammad Riaz ,&nbsp;Adeel Ahmed ,&nbsp;Mubin Mustafa Kiyani ,&nbsp;Sahibzada Muhammad Jawad ,&nbsp;Syed Shahab Ud Din Shah ,&nbsp;Turki Abualait ,&nbsp;Fawaz Al-hussain ,&nbsp;Hong-Tao Li ,&nbsp;Shahid Bashir","doi":"10.1016/j.reth.2025.07.009","DOIUrl":"10.1016/j.reth.2025.07.009","url":null,"abstract":"<div><div>Amyotrophic Lateral Sclerosis (ALS) is a complex neurodegenerative disorder characterized by the death of motor neurons in the spinal cord and brain regions, leading to a reduced survival rate in patients. Nearly 20 gene mutations are associated with ALS, with SOD1, FUS, TARDBP, and C9orf72 mutations being more common. Ninety percent of ALS cases are related to sporadic ALS, while the remaining 10 % are associated with familial ALS. CRISPR/Cas9, a genome engineering technology known as clustered regularly interspaced short palindromic repeats/CRISPR-associated system 9, has the potential for gene editing and for studying the underlying mechanisms of ALS in mouse models. This technique enables neuroscientists to reverse mutations found in ALS mouse models, providing new hope for understanding the complexities of ALS. Additionally, this tool can create mutations to probe the functional changes of genetic diseases. Using CRISPR/Cas9 with an in vivo delivery method involving adeno-associated vectors, it is possible to silence mutations in the SOD1-linked ALS mouse model. Some limitations related to CRISPR/Cas9 have been discussed in previous studies and need to be addressed before clinical trials can proceed. In this review-based study, we summarise the latest research on CRISPR/Cas9 genome editing for ALS in mouse models and discuss its limitations and future prospects as well.</div></div>","PeriodicalId":20895,"journal":{"name":"Regenerative Therapy","volume":"30 ","pages":"Pages 575-583"},"PeriodicalIF":3.5,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144830685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tanshinone IIA suppresses fibro-adipogenic progenitor differentiation and attenuates fat infiltration in rotator cuff injury via Wnt/β-catenin pathway 丹参酮IIA通过Wnt/β-catenin通路抑制肌腱套损伤中纤维脂肪祖细胞分化并减轻脂肪浸润
IF 3.5 3区 环境科学与生态学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-08-13 DOI: 10.1016/j.reth.2025.08.004
Yumei Zhang , Xinghua Li , Rui Zhang , Minhui Wang , Tihui Wang , Guanfeng Liu , Amila Kuati , Wenhua Mao

Background

Fibro-adipogenic progenitors (FAPs) contribute to excessive muscular fatty infiltration after rotator cuff tears (RCT), impairing shoulder function. Tanshinone IIA (Tan IIA), a major active compound from Salvia miltiorrhiza Bunge, has known anti-adipogenic effects, yet its impact on FAP adipogenesis remains unclear.

Methods

Human FAPs from rotator cuff muscles were isolated via FACS, cultured, and treated with Tan IIA. Adipogenic differentiation was assessed with Oil Red O staining and RT-qPCR for lipid accumulation and gene expression. Single-cell RNA sequencing identified affected FAP subpopulations, while pathway analysis and Western blots confirmed Wnt/β-catenin pathway activation. β-catenin inhibitors KYA1797K and XAV-939 were then applied to evaluate pathway specificity. In vivo, RCT models received Tan IIA treatment, with Plin1 staining and triglyceride quantification measuring fatty infiltration, and gait and treadmill tests assessing shoulder function.

Results

Tan IIA reduced adipogenic differentiation of FAPs in vitro, as shown by Oil Red O staining and RT-qPCR. Single-cell RNA sequencing indicated that Tan IIA reduced adipogenic potential in specific FAP populations. Enrichment analysis and Western blot results confirmed Wnt/β-catenin pathway activation by Tan IIA. Anti-adipogenic effects were reversed with β-catenin inhibitors. In vivo, Tan IIA significantly reduced muscular fatty infiltration and improved shoulder function in RCT models.

Conclusion

Tan IIA inhibits FAP adipogenesis through Wnt/β-catenin signaling activation, reducing fatty infiltration and enhancing shoulder function in RCT, suggesting Tan IIA as a potential treatment.
背景纤维脂肪源性祖细胞(FAPs)导致肩袖撕裂(RCT)后肌肉脂肪过度浸润,损害肩功能。丹参酮IIA (Tan IIA)是丹参中的一种主要活性化合物,已知具有抗脂肪生成作用,但其对FAP脂肪生成的影响尚不清楚。方法采用流式细胞术(FACS)分离、培养、Tan IIA处理人肩袖肌FAPs。采用油红O染色和RT-qPCR检测脂质积累和基因表达。单细胞RNA测序鉴定了受影响的FAP亚群,而通路分析和Western blot证实了Wnt/β-catenin通路的激活。然后应用β-catenin抑制剂KYA1797K和XAV-939来评估通路特异性。在体内,RCT模型接受Tan IIA治疗,Plin1染色和甘油三酯量化测量脂肪浸润,步态和跑步机测试评估肩部功能。结果经油红O染色和RT-qPCR检测,stan IIA可抑制FAPs体外成脂分化。单细胞RNA测序表明,Tan IIA降低了特定FAP群体的脂肪生成潜力。富集分析和Western blot结果证实Tan IIA激活了Wnt/β-catenin通路。β-catenin抑制剂的抗脂肪生成作用被逆转。在体内,Tan IIA在RCT模型中显著减少肌肉脂肪浸润并改善肩部功能。结论在RCT研究中,Tan IIA通过激活Wnt/β-catenin信号通路抑制FAP脂肪生成,减少脂肪浸润,增强肩关节功能,提示Tan IIA是一种潜在的治疗方法。
{"title":"Tanshinone IIA suppresses fibro-adipogenic progenitor differentiation and attenuates fat infiltration in rotator cuff injury via Wnt/β-catenin pathway","authors":"Yumei Zhang ,&nbsp;Xinghua Li ,&nbsp;Rui Zhang ,&nbsp;Minhui Wang ,&nbsp;Tihui Wang ,&nbsp;Guanfeng Liu ,&nbsp;Amila Kuati ,&nbsp;Wenhua Mao","doi":"10.1016/j.reth.2025.08.004","DOIUrl":"10.1016/j.reth.2025.08.004","url":null,"abstract":"<div><h3>Background</h3><div>Fibro-adipogenic progenitors (FAPs) contribute to excessive muscular fatty infiltration after rotator cuff tears (RCT), impairing shoulder function. Tanshinone IIA (Tan IIA), a major active compound from Salvia miltiorrhiza Bunge, has known anti-adipogenic effects, yet its impact on FAP adipogenesis remains unclear.</div></div><div><h3>Methods</h3><div>Human FAPs from rotator cuff muscles were isolated via FACS, cultured, and treated with Tan IIA. Adipogenic differentiation was assessed with Oil Red O staining and RT-qPCR for lipid accumulation and gene expression. Single-cell RNA sequencing identified affected FAP subpopulations, while pathway analysis and Western blots confirmed Wnt/β-catenin pathway activation. β-catenin inhibitors KYA1797K and XAV-939 were then applied to evaluate pathway specificity. In vivo, RCT models received Tan IIA treatment, with Plin1 staining and triglyceride quantification measuring fatty infiltration, and gait and treadmill tests assessing shoulder function.</div></div><div><h3>Results</h3><div>Tan IIA reduced adipogenic differentiation of FAPs in vitro, as shown by Oil Red O staining and RT-qPCR. Single-cell RNA sequencing indicated that Tan IIA reduced adipogenic potential in specific FAP populations. Enrichment analysis and Western blot results confirmed Wnt/β-catenin pathway activation by Tan IIA. Anti-adipogenic effects were reversed with β-catenin inhibitors. In vivo, Tan IIA significantly reduced muscular fatty infiltration and improved shoulder function in RCT models.</div></div><div><h3>Conclusion</h3><div>Tan IIA inhibits FAP adipogenesis through Wnt/β-catenin signaling activation, reducing fatty infiltration and enhancing shoulder function in RCT, suggesting Tan IIA as a potential treatment.</div></div>","PeriodicalId":20895,"journal":{"name":"Regenerative Therapy","volume":"30 ","pages":"Pages 584-594"},"PeriodicalIF":3.5,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144830687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From an Antimicrobial Agent to a constituent of 3D Printed Heterogenous Scaffolds Stimulating Bone Characteristics: An In-vitro and Animal model evaluation 从抗菌剂到3D打印异质支架刺激骨特性的成分:体外和动物模型评估
IF 3.5 3区 环境科学与生态学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-08-12 DOI: 10.1016/j.reth.2025.08.001
Shahad Ahmed Daood , Martha Then Xin Yi , Nicole Wen Ce Mun , Sharjeel Ilyas , Lee Yin Shien , Oh Jia En , Syed Saad Bin Qasim , Yichen Dai , Galvinderjeet Kaur Grewal , Ng Mei Liit , Gopu Sriram , Malikarjuna Rao Pichika , Kit-Kay Mak , Ranjeet Ajit Bapat , Zeeshan Sheikh , Umer Daood
This paper describes a promising candidate molecule, investigates the pattern of scaffold composition which arises and assesses the effect of the agent on its mechanical properties.

Methods

Scaffold samples were fabricated using a commercial extrusion bioprinter equipped with a pneumatic printhead fitted with a 21G conical nozzle. The Pore Printability Index, and the area and perimeter of the pore within the grid patterns were quantified using ImageJ software (NIH, USA). Mechanical properties of scaffolds were assessed using atomic force microscopy. The phase composition and crystal structures were analyzed using X-ray diffraction and Raman mapping. Morphologies of human gingival fibroblastic cells were examined using scanning electron microscopy. Lactobacillus biofilms were generated for cytolysin peptide cleavage. A rabbit bone defect model with scaffold implantations was used to provide histologic specimens for measuring percentages of bone trabeculae, collagen fibers and inflammatory cells along with granulation tissue. The Primeway Total RNA Extraction Kit was used for RNA extraction.

Results

All bioink formulations demonstrated successful printing of 3D grid and solid square patterned scaffolds achieving Pr values exceeding 0.9. 0.1 %K21 group showed the highest elastic modulus. XRD revealed a pattern producing around 90 % β-tricalcium phosphate displaying two peaks at 2θ angles. 0.1 % K21 and 0.1 %CHX did not alter scaffold's pore size and porosity. 0.1 %K21 group exhibited highest ratio (62.5 ± 6.1 θ), significantly surpassing control. Surface morphologies of cells were also well retained. TEM image shows a sequence of structural changes in fibroblastic cell structure when exposed to K21. 0.1 % K21 proved to be critical in completely eradicating the biofilm. 0.K21 group closed the openings of wound areas completely. Correlation coefficient of gene expression levels demonstrates sample variations and recurring instances among groupings.

Conclusion

3D-printing technologies with 0.1 %K21 represent a significant advancement over conventional regenerative medicine techniques for bone-related treatments.
本文描述了一个有前途的候选分子,研究了支架组成的模式,并评估了该剂对其力学性能的影响。方法采用商用挤压生物打印机制备支架样品,该打印机配备21G锥形喷嘴的气动打印头。使用ImageJ软件(NIH, USA)对孔隙可打印性指数以及网格模式内孔隙的面积和周长进行量化。采用原子力显微镜观察支架的力学性能。利用x射线衍射和拉曼图分析了相组成和晶体结构。用扫描电镜观察了人牙龈成纤维细胞的形态。制备乳酸菌生物膜裂解细胞溶素肽。采用支架植入兔骨缺损模型提供组织学标本,测定骨小梁、胶原纤维、炎性细胞及肉芽组织的百分比。采用Primeway总RNA提取试剂盒进行RNA提取。结果所有生物墨水配方均成功打印出三维网格和实心方形支架,Pr值均超过0.9。0.1% K21组弹性模量最高。XRD谱图显示,β-磷酸三钙含量约为90%,在2θ角处有两个峰。0.1%的K21和0.1%的CHX没有改变支架的孔径和孔隙率。0.1% K21组比例最高(62.5±6.1 θ),显著高于对照组。细胞的表面形态也保留得很好。TEM图像显示了暴露于K21时成纤维细胞结构的一系列结构变化。0.1%的K21被证明是完全根除生物膜的关键。0.K21组完全闭合创面开口。基因表达水平的相关系数显示了样本差异和组间反复出现的情况。结论添加0.1% K21的3d打印技术在骨相关治疗方面是传统再生医学技术的重大进步。
{"title":"From an Antimicrobial Agent to a constituent of 3D Printed Heterogenous Scaffolds Stimulating Bone Characteristics: An In-vitro and Animal model evaluation","authors":"Shahad Ahmed Daood ,&nbsp;Martha Then Xin Yi ,&nbsp;Nicole Wen Ce Mun ,&nbsp;Sharjeel Ilyas ,&nbsp;Lee Yin Shien ,&nbsp;Oh Jia En ,&nbsp;Syed Saad Bin Qasim ,&nbsp;Yichen Dai ,&nbsp;Galvinderjeet Kaur Grewal ,&nbsp;Ng Mei Liit ,&nbsp;Gopu Sriram ,&nbsp;Malikarjuna Rao Pichika ,&nbsp;Kit-Kay Mak ,&nbsp;Ranjeet Ajit Bapat ,&nbsp;Zeeshan Sheikh ,&nbsp;Umer Daood","doi":"10.1016/j.reth.2025.08.001","DOIUrl":"10.1016/j.reth.2025.08.001","url":null,"abstract":"<div><div>This paper describes a promising candidate molecule, investigates the pattern of scaffold composition which arises and assesses the effect of the agent on its mechanical properties.</div></div><div><h3>Methods</h3><div>Scaffold samples were fabricated using a commercial extrusion bioprinter equipped with a pneumatic printhead fitted with a 21G conical nozzle. The Pore Printability Index, and the area and perimeter of the pore within the grid patterns were quantified using ImageJ software (NIH, USA). Mechanical properties of scaffolds were assessed using atomic force microscopy. The phase composition and crystal structures were analyzed using X-ray diffraction and Raman mapping. Morphologies of human gingival fibroblastic cells were examined using scanning electron microscopy. Lactobacillus biofilms were generated for cytolysin peptide cleavage. A rabbit bone defect model with scaffold implantations was used to provide histologic specimens for measuring percentages of bone trabeculae, collagen fibers and inflammatory cells along with granulation tissue. The Primeway Total RNA Extraction Kit was used for RNA extraction.</div></div><div><h3>Results</h3><div>All bioink formulations demonstrated successful printing of 3D grid and solid square patterned scaffolds achieving Pr values exceeding 0.9. <sub><strong>0.1</strong> <strong>%</strong></sub><strong>K21</strong> group showed the highest elastic modulus. XRD revealed a pattern producing around 90 % β-tricalcium phosphate displaying two peaks at 2θ angles. 0.1 % K21 and <sub><strong>0.1</strong> <strong>%</strong></sub><strong>CHX</strong> did not alter scaffold's pore size and porosity. <sub><strong>0.1</strong> <strong>%</strong></sub><strong>K21</strong> group exhibited highest ratio (62.5 ± 6.1 θ), significantly surpassing control. Surface morphologies of cells were also well retained. TEM image shows a sequence of structural changes in fibroblastic cell structure when exposed to K21. 0.1 % K21 proved to be critical in completely eradicating the biofilm. <strong><sub>0.</sub>K21</strong> group closed the openings of wound areas completely. Correlation coefficient of gene expression levels demonstrates sample variations and recurring instances among groupings.</div></div><div><h3>Conclusion</h3><div>3D-printing technologies with <sub><strong>0.1</strong> <strong>%</strong></sub><strong>K21</strong> represent a significant advancement over conventional regenerative medicine techniques for bone-related treatments.</div></div>","PeriodicalId":20895,"journal":{"name":"Regenerative Therapy","volume":"30 ","pages":"Pages 558-574"},"PeriodicalIF":3.5,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144826956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hydrogel in musculoskeletal diseases: Unraveling trends, research foci, and future trajectories via bibliometric insights (from 2000 to 2025) 水凝胶在肌肉骨骼疾病中的应用:通过文献计量学分析揭示趋势、研究重点和未来发展轨迹(从2000年到2025年)
IF 3.5 3区 环境科学与生态学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-08-06 DOI: 10.1016/j.reth.2025.08.002
Weibei Sheng , Siyang Cao , Haotian Qin , Peng Liu , Deli Wang , Jian Weng , Hui Zeng , Fei Yu

Introduction

Hydrogels, owing to their excellent biocompatibility, tunable physicochemical properties, and ability to mimic the extracellular matrix, have emerged as promising materials for the treatment of musculoskeletal disorders, including osteoarthritis, intervertebral disc degeneration, and bone injuries. Recent advancements in smart hydrogels and multifunctional composites have further broadened their applications in drug delivery, tissue engineering, and regenerative medicine. However, despite growing interest in this field, current reviews often lack systematic, data-driven insights into the evolving research landscape.

Methods

To address this gap, we conducted a bibliometric analysis using CiteSpace and VOSviewer to quantitatively map the development of hydrogel-related research in musculoskeletal disorders over the past two decades. Key parameters analyzed included publication trends, influential countries and institutions, collaborative networks, keyword evolution, and research hotspots.

Results

Our analysis revealed a steady growth in publications, with China and the United States emerging as leading contributors. Prominent institutions and authors were identified, along with landmark publications that have shaped the field. Keyword co-occurrence analysis highlighted emerging themes such as injectable hydrogels, 3D bioprinting, and osteochondral regeneration. The most frequently studied disease targets included osteoarthritis, intervertebral disc degeneration, and bone defect repair.

Conclusions

This comprehensive bibliometric overview offers valuable insights into the current status and future directions of hydrogel research in musculoskeletal disorders. It highlights key trends, influential contributors, and emerging hotspots, providing a solid foundation for advancing interdisciplinary collaborations and accelerating the clinical translation of hydrogel-based therapies.
水凝胶由于其优异的生物相容性、可调节的物理化学性质和模拟细胞外基质的能力,已成为治疗肌肉骨骼疾病(包括骨关节炎、椎间盘退变和骨损伤)的有前途的材料。智能水凝胶和多功能复合材料的最新进展进一步拓宽了它们在药物输送、组织工程和再生医学方面的应用。然而,尽管人们对这一领域的兴趣日益浓厚,但目前的综述往往缺乏对不断发展的研究前景的系统的、数据驱动的见解。为了弥补这一空白,我们使用CiteSpace和VOSviewer进行了文献计量分析,定量绘制了过去20年水凝胶相关研究在肌肉骨骼疾病中的发展。分析的关键参数包括出版趋势、有影响力的国家和机构、合作网络、关键词演变和研究热点。结果:我们的分析显示,论文发表量稳步增长,中国和美国成为主要贡献者。突出的机构和作者,以及具有里程碑意义的出版物,塑造了该领域。关键词共现分析突出了可注射水凝胶、3D生物打印和骨软骨再生等新兴主题。最常研究的疾病目标包括骨关节炎、椎间盘退变和骨缺损修复。这一全面的文献计量学综述为水凝胶在肌肉骨骼疾病中的研究现状和未来方向提供了有价值的见解。它突出了关键趋势、有影响力的贡献者和新兴热点,为推进跨学科合作和加速水凝胶疗法的临床转化提供了坚实的基础。
{"title":"Hydrogel in musculoskeletal diseases: Unraveling trends, research foci, and future trajectories via bibliometric insights (from 2000 to 2025)","authors":"Weibei Sheng ,&nbsp;Siyang Cao ,&nbsp;Haotian Qin ,&nbsp;Peng Liu ,&nbsp;Deli Wang ,&nbsp;Jian Weng ,&nbsp;Hui Zeng ,&nbsp;Fei Yu","doi":"10.1016/j.reth.2025.08.002","DOIUrl":"10.1016/j.reth.2025.08.002","url":null,"abstract":"<div><h3>Introduction</h3><div>Hydrogels, owing to their excellent biocompatibility, tunable physicochemical properties, and ability to mimic the extracellular matrix, have emerged as promising materials for the treatment of musculoskeletal disorders, including osteoarthritis, intervertebral disc degeneration, and bone injuries. Recent advancements in smart hydrogels and multifunctional composites have further broadened their applications in drug delivery, tissue engineering, and regenerative medicine. However, despite growing interest in this field, current reviews often lack systematic, data-driven insights into the evolving research landscape.</div></div><div><h3>Methods</h3><div>To address this gap, we conducted a bibliometric analysis using CiteSpace and VOSviewer to quantitatively map the development of hydrogel-related research in musculoskeletal disorders over the past two decades. Key parameters analyzed included publication trends, influential countries and institutions, collaborative networks, keyword evolution, and research hotspots.</div></div><div><h3>Results</h3><div>Our analysis revealed a steady growth in publications, with China and the United States emerging as leading contributors. Prominent institutions and authors were identified, along with landmark publications that have shaped the field. Keyword co-occurrence analysis highlighted emerging themes such as injectable hydrogels, 3D bioprinting, and osteochondral regeneration. The most frequently studied disease targets included osteoarthritis, intervertebral disc degeneration, and bone defect repair.</div></div><div><h3>Conclusions</h3><div>This comprehensive bibliometric overview offers valuable insights into the current status and future directions of hydrogel research in musculoskeletal disorders. It highlights key trends, influential contributors, and emerging hotspots, providing a solid foundation for advancing interdisciplinary collaborations and accelerating the clinical translation of hydrogel-based therapies.</div></div>","PeriodicalId":20895,"journal":{"name":"Regenerative Therapy","volume":"30 ","pages":"Pages 544-557"},"PeriodicalIF":3.5,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144780154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The therapeutic potential of neuroglobin-overexpressing human neural stem cells in a photothrombosis model 过表达神经球蛋白的人神经干细胞在光血栓模型中的治疗潜力
IF 3.5 3区 环境科学与生态学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-08-05 DOI: 10.1016/j.reth.2025.07.013
Eun-Jung Yoon , Jiwon Jeong , Jisu An , Yunseo Choi , Dongsun Park

Background

Neuroglobin (NGB) is an oxygen-binding protein with neuroprotective properties under hypoxic and ischemic conditions. It promotes cell survival, reduces oxidative stress, and activates survival-related signaling pathways. This study aimed to evaluate whether overexpression of NGB in human neural stem cells (F3.NGB) could enhance their regenerative potential and therapeutic efficacy in photothrombosis model.

Methods

F3 cells were genetically engineered to overexpress NGB. In vitro proliferation and migration were assessed using CCK-8, colony forming, and scratch-based wound healing assays. In vivo, a photothrombosis-induced stroke model was used to evaluate infarct volume, transplanted cell migration and differentiation, and activation of proliferation-related signaling pathways following intravenous transplantation of F3.NGB cells.

Results

NGB overexpression significantly enhanced the proliferative capacity of F3 cells, and F3.NGB cells promoted N2A cell proliferation and actively migrated in co-culture conditions. In vivo, transplantation of F3.NGB cells resulted in a significant reduction in infarct volume compared with that in the controls. Western blot analysis showed increased activation of PI3K/AKT, mTOR, and ERK signaling pathways, with decreased PTEN expression. Immunohistochemical staining confirmed that F3.NGB cells migrated to the infarcted region, differentiated into neurons and astrocytes, and showed strong Ki67 positivity, indicating active proliferation at the injury site.

Conclusion

These findings demonstrate that F3.NGB cells reduce ischemic brain damage primarily by enhancing cell proliferation, and also migrate to the injury site and undergo differentiation into neurons or astrocytes. These results suggest that F3.NGB cell-based therapy may contribute to the development of advanced regenerative strategies for the treatment of ischemic stroke.
神经红蛋白(NGB)是一种氧结合蛋白,在缺氧和缺血条件下具有神经保护作用。它促进细胞存活,减少氧化应激,激活与生存相关的信号通路。本研究旨在评价NGB在人神经干细胞(F3.NGB)中的过表达是否能增强其光血栓形成模型的再生潜能和治疗效果。方法利用基因工程技术使sf3细胞过表达NGB。使用CCK-8、菌落形成和基于划痕的伤口愈合试验评估体外增殖和迁移。在体内,使用光血栓诱导的卒中模型来评估静脉内F3移植后的梗死体积、移植细胞迁移和分化以及增殖相关信号通路的激活。NGB细胞。结果sngb过表达可显著增强F3细胞的增殖能力;在共培养条件下,NGB细胞促进N2A细胞增殖并积极迁移。体内,移植F3。与对照组相比,NGB细胞导致梗死体积显著减少。Western blot分析显示,PI3K/AKT、mTOR和ERK信号通路激活增加,PTEN表达降低。免疫组化染色证实F3。NGB细胞向梗死区迁移,分化为神经元和星形胶质细胞,Ki67呈强阳性,表明损伤部位增殖活跃。结论F3。NGB细胞主要通过增强细胞增殖来减轻缺血性脑损伤,并向损伤部位迁移并分化为神经元或星形胶质细胞。这些结果表明F3。NGB细胞为基础的治疗可能有助于发展先进的再生策略治疗缺血性卒中。
{"title":"The therapeutic potential of neuroglobin-overexpressing human neural stem cells in a photothrombosis model","authors":"Eun-Jung Yoon ,&nbsp;Jiwon Jeong ,&nbsp;Jisu An ,&nbsp;Yunseo Choi ,&nbsp;Dongsun Park","doi":"10.1016/j.reth.2025.07.013","DOIUrl":"10.1016/j.reth.2025.07.013","url":null,"abstract":"<div><h3>Background</h3><div>Neuroglobin (NGB) is an oxygen-binding protein with neuroprotective properties under hypoxic and ischemic conditions. It promotes cell survival, reduces oxidative stress, and activates survival-related signaling pathways. This study aimed to evaluate whether overexpression of NGB in human neural stem cells (F3.NGB) could enhance their regenerative potential and therapeutic efficacy in photothrombosis model.</div></div><div><h3>Methods</h3><div>F3 cells were genetically engineered to overexpress NGB. In vitro proliferation and migration were assessed using CCK-8, colony forming, and scratch-based wound healing assays. In vivo, a photothrombosis-induced stroke model was used to evaluate infarct volume, transplanted cell migration and differentiation, and activation of proliferation-related signaling pathways following intravenous transplantation of F3.NGB cells.</div></div><div><h3>Results</h3><div>NGB overexpression significantly enhanced the proliferative capacity of F3 cells, and F3.NGB cells promoted N2A cell proliferation and actively migrated in co-culture conditions. In vivo, transplantation of F3.NGB cells resulted in a significant reduction in infarct volume compared with that in the controls. Western blot analysis showed increased activation of PI3K/AKT, mTOR, and ERK signaling pathways, with decreased PTEN expression. Immunohistochemical staining confirmed that F3.NGB cells migrated to the infarcted region, differentiated into neurons and astrocytes, and showed strong Ki67 positivity, indicating active proliferation at the injury site.</div></div><div><h3>Conclusion</h3><div>These findings demonstrate that F3.NGB cells reduce ischemic brain damage primarily by enhancing cell proliferation, and also migrate to the injury site and undergo differentiation into neurons or astrocytes. These results suggest that F3.NGB cell-based therapy may contribute to the development of advanced regenerative strategies for the treatment of ischemic stroke.</div></div>","PeriodicalId":20895,"journal":{"name":"Regenerative Therapy","volume":"30 ","pages":"Pages 515-524"},"PeriodicalIF":3.5,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144772686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Regenerative Therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1